High endoplasmic reticulum activity renders multiple myeloma cells hypersensitive to mitochondrial inhibitors

Area of Science:

• Cell Biology
• Cancer Biology
• Mitochondrial Biology

Background:

• Multiple myeloma (MM) cells secrete large amounts of immunoglobulins, requiring high endoplasmic reticulum (ER) activity.
• Mitochondria capture and return leaked Ca(2+) from the ER to maintain ER lumen Ca(2+) homeostasis.
• High ER activity in MM cells suggests a potentially greater reliance on mitochondrial Ca(2+) regulation.

Purpose of the Study:

• To investigate the hypothesis that MM cells' high ER activity leads to increased mitochondrial Ca(2+) regulation.
• To determine if MM cells are more sensitive to mitochondrial inhibitors compared to other B-cell leukemia lines.
• To explore the therapeutic potential of mitochondrial inhibitors in MM.

Main Methods:

• Compared Ca(2+) leak in ER from MM cells versus B-cell leukemia cells.
• Assessed sensitivity of MM cells to various mitochondrial inhibitors (e.g., CCCP).
• Measured the unfolded protein response marker CHOP/GADD153 induction by CCCP.
• Evaluated MM cell sensitivity to clinically used fenofibrate and troglitazone.

Main Results:

• MM cells exhibited greater ER Ca(2+) leak compared to B-cell leukemia cells.
• MM cells showed hypersensitivity to mitochondrial inhibitors, including CCCP.
• CCCP more potently induced CHOP/GADD153 in MM cells.
• MM cells were significantly more sensitive to fenofibrate and troglitazone.

Conclusions:

• Unusually high ER activity in MM cells increases their reliance on mitochondrial Ca(2+) regulation.
• This heightened dependence renders MM cells susceptible to mitochondrial inhibitors.
• Mitochondrial inhibitors, such as fenofibrate and troglitazone, represent a potential therapeutic strategy for multiple myeloma.